| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.00▼ | 2.00▼ | 2.00▼ | 2.03▼ | 2.38▼ |
| MA10 | 2.02▼ | 2.03▼ | 2.04▼ | 2.18▼ | 3.03▼ |
| MA20 | 2.09▼ | 2.14▼ | 2.18▼ | 2.36▼ | 4.03▼ |
| MA50 | 2.37▼ | 2.55▼ | 2.66▼ | 3.23▼ | 4.13▼ |
| MA100 | 3.00▼ | 3.31▼ | 3.46▼ | 4.12▼ | 3.21▼ |
| MA200 | 3.92▼ | 4.10▼ | 4.25▼ | 4.29▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.009▲ | 0.011▲ | 0.010▲ | 0.010▲ | N/A |
| RSI | 27.793▼ | 27.215▼ | 27.111▼ | 30.236▼ | N/A |
| STOCH | 18.182▼ | 7.640▼ | 5.682▼ | 10.992▼ | 7.517▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -96.296▼ | -99.118▼ |
| CCI | -152.198▼ | -122.605▼ | -110.409▼ | -125.739▼ | -116.492▼ |
|
Thursday, December 13, 2018 06:49 AM
The first patient has been dosed in a Phase 1/1b clinical trial evaluating Aptevo Therapeutics' (APVO) APVO0436, an anti-CD123 x CD3 bispecific antibody, in patients with acute myeloid leukemia ...
|
|
Thursday, December 13, 2018 05:02 AM
Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, announced today that the first patient has been dosed in a Phase ...
|
|
Wednesday, December 12, 2018 05:07 AM
Aptevo Therapeutics Inc (NASDAQ: APVO) Biocept Inc (NASDAQ: BIOC) BIOLASE Inc (NASDAQ: BIOL) Cidara Therapeutics Inc (NASDAQ: CDTX) Corvus Pharmaceuticals Inc (NASDAQ: CRVS) Curis, Inc. (NASDAQ: CRIS) ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/12/18 | 1.97 | 2.02 | 1.93 | 1.95 | 87,147 |
| 13/12/18 | 2.15 | 2.15 | 1.92 | 2.00 | 93,800 |
| 12/12/18 | 2.06 | 2.15 | 2.00 | 2.15 | 53,736 |
| 11/12/18 | 2.07 | 2.14 | 2.00 | 2.00 | 69,492 |
| 10/12/18 | 2.24 | 2.24 | 2.04 | 2.05 | 102,085 |
| 07/12/18 | 2.27 | 2.336 | 2.10 | 2.20 | 41,500 |
| 06/12/18 | 2.36 | 2.41 | 2.22 | 2.26 | 95,468 |
| 04/12/18 | 2.48 | 2.5048 | 2.36 | 2.41 | 46,313 |
| 03/12/18 | 2.34 | 2.51 | 2.3219 | 2.48 | 79,517 |
| 30/11/18 | 2.37 | 2.38 | 2.28 | 2.30 | 43,010 |
|
|
||||
|
|
||||
|
|
||||
|
|